This Group aims to stimulate preclinical and clinical research of anticancer drug effects and drug-related molecular pathology. PAMM is an integral part of the EORTC’s Translational Research Division, delivering information for projects with other disease-oriented groups, particularly in early-stage development.


Want to read in detail our scientific findings on specific tumour type?
Search through our comprehensive list of EORTC published articles to date.